Numinus Wellness (NUMI.V) is cleared by Health Canada to work with MAPS on MDMA therapy for PTSD

Numinus Wellness (NUMI.V) announced that Health Canada has cleared their MAPS-sponsored single-arm, open-label safety and feasibility study evaluating MDMA-assisted therapy for post-traumatic stress disorder (PTSD).